Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2024
Total Assets: $92.60B
Liabilities Breakdown FY2024
Total Liabilities: $76.22B
Asset Breakdown
Total Assets: $92.60B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.35B | 11.2% |
| Accounts Receivable | $9.01B | 9.7% |
| Inventory | $2.56B | 2.8% |
| Property, Plant & Equipment | $7.14B | 7.7% |
| Goodwill | $21.72B | 23.5% |
| Intangible Assets | $23.31B | 25.2% |
| Other Assets | $18.53B | 20.0% |
Liabilities Breakdown
Total Liabilities: $76.22B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.60B | 4.7% |
| Long-Term Debt | $47.60B | 62.5% |
| Other Liabilities | $25.01B | 32.8% |